10q10k10q10k.net
QuidelOrtho Corp

QuidelOrtho CorpQDELEarnings & Financial Report

Nasdaq · health care industry

QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.

QDEL Q3 2026 Key Financial Metrics

Revenue

$699.9M

Gross Profit

N/A

Operating Profit

$-704.8M

Net Profit

$-733.0M

Gross Margin

N/A

Operating Margin

-100.7%

Net Margin

-104.7%

YoY Growth

-3.7%

EPS

$-10.78

Financial Flow

QuidelOrtho Corp Q3 2026 Financial Summary

QuidelOrtho Corp reported revenue of $699.9M for Q3 2026, with a net profit of $-733.0M (-104.7% margin). Cost of goods sold was N/A, operating expenses totaled N/A.

Key Financial Metrics

Total Revenue$699.9M
Net Profit$-733.0M
Gross MarginN/A
Operating Margin-100.7%
Report PeriodQ3 2026

QuidelOrtho Corp Annual Revenue by Year

QuidelOrtho Corp annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.8B).

YearAnnual Revenue
2025$2.8B
2024$3.0B

Income Statement

Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Revenue$742.6M$711.0M$637.0M$727.1M$707.8M$692.8M$613.9M$699.9M
YoY Growth-14.3%-16.0%-4.2%-2.3%-4.7%-2.6%-3.6%-3.7%

Balance Sheet

Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Assets$8.56B$6.70B$6.69B$6.80B$6.42B$6.46B$6.38B$5.68B
Liabilities$3.56B$3.40B$3.52B$3.61B$3.44B$3.46B$3.59B$3.64B
Equity$5.01B$3.31B$3.17B$3.19B$2.98B$3.00B$2.79B$2.04B

Cash Flow

Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Operating CF$80.4M$-700000$-97.9M$117.9M$63.7M$65.6M$-46.8M$-45.5M